Emergency-response vaccine platforms
Platform technologies that shorten the path from threat to vaccine, replacing slow case-by-case development — coordinated across drug substance, drug product, formulation, analytics and manufacturing; delivered by groups such as Moderna, BioNTech, CanSinoBIO and the University of Queensland.
1 · What it gives
Emergency-response vaccine platforms replace traditional, slower development that needs long timelines for research, clinical testing and building manufacturing capacity. A platform involves coordinated technical development in several areas, including drug substance and drug product processing, formulation and stability, and analytics. Companies and institutions named as delivering platforms include the University of Queensland, CanSinoBIO, Moderna and BioNTech.
2 · What it replaces 6
| D1 | Fermentation (stainless and single-use bioreactors, solid-state reactors) and downstream equipment (centrifuges, filtration, spray and fluid-bed drying, formulation) for local production of enzymes, microbial products and fermentation ingredients instead of chemical-synthesis plants and imports Replaces: Chemical-synthesis routes and imports for the products in FI-, FD-, I- and A-series articles (enzymes, organic acids, vitamins, microbial … | EAC |
| D0 | Bacteriophage therapy for bacterial disease in fish and shrimp farming instead of medicated-feed antibiotics Replaces: Antibiotics in medicated feed and bath treatments - oxytetracycline, florfenicol, oxolinic acid, enrofloxacin, sulfonamide-trimethoprim … | VET |
| D2 | Cattle tick control with the Bm86 anti-tick vaccine, tick-resistant breeds, pasture spelling and entomopathogenic fungi (Metarhizium) Replaces: Frequent acaricide dipping/spraying/pour-on with organophosphates (coumaphos, diazinon, chlorpyrifos), synthetic pyrethroids (cypermethrin, … | VET |
| D1 | Piglet post-weaning diarrhoea without pharmacological zinc oxide and colistin — live oral E. coli vaccine, fermented liquid feed, probiotics and low-protein diets Replaces: Pharmacological zinc oxide (2,500–3,000 ppm Zn in feed), colistin, apramycin/neomycin and other in-feed or in-water antibiotics for weaner … | FEED |
| D1 | Biosurfactants (rhamnolipids, sophorolipids) instead of petrochemical surfactants in cleaning and industrial formulation Replaces: Petrochemical surfactants in cleaners and formulations - linear alkylbenzene sulfonate (LAS), alcohol ethoxylates (AEO), alkylphenol … | CHEM |
| D2 | Bumblebee pollination instead of hormone sprays and manual vibration in greenhouse tomatoes Replaces: Fruit-setting hormone sprays (synthetic auxins such as 4-CPA / tomatotone) and labour-intensive manual flower vibration in greenhouse … | MACRO |
3 · How to implement 3 steps
- 1Substance and product processingDevelop drug-substance and drug-product processing.
- 2Formulation and stabilityDevelop formulation and stability.
- 3Analytics and manufacturingBuild analytical methods and manufacturing comparability.
4 · Who delivers
Matched suppliers (matched automatically)
| Avani | Indonesia | Producer | active |
| Vland Biotech 蔚蓝生物 (SSE 603739) | China | Research / RTO | active |
| Liselo Labs | South Africa | Research / RTO | active |
| Accra Compost and Recycling Plant Limited | Ghana | Producer | active |
| BioTerra | Uruguay | Services / consulting | active |
| Biocamp Laboratórios Ltda | Brazil | Research / RTO | active |
| Endolith | United States | Not classified | active |
| Insect Science | South Africa | Producer | active |
| Vaksindo Animal Health | Indonesia | Research / RTO | active |
| FENRI Co., Ltd. | Taiwan | Not classified | active |
| Fermelanta | Japan | Producer | active |
| AGROSAVIA | Colombia | Research / RTO | active |
Leading companies and institutes (from the brief)
The University of Queensland, CanSinoBIO, Moderna and BioNTech are named. Others are matched by the portal under Pharma & biologics and Biosecurity.
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
National regulatory agencies and international bodies such as the WHO govern development and emergency use; the sources give no EU-specific instrument.
China
The sources point to Chinese national regulators for development and emergency use without naming a specific instrument.
6 · Money: tenders & grants
7 · Tech stack & innovations
Main risks from the sources: regulatory hurdles, technical complexity of manufacturing comparability and scale-up, and uncertain market demand after a pandemic.
Sources 4
- Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16
- Cepi.net — cepi.net 2026-10-16
- Nhc.gov.cn — www.nhc.gov.cn 2026-10-16
- Pmc.ncbi.nlm.nih.gov — pmc.ncbi.nlm.nih.gov 2026-10-16